Levocetirizine Dihydrochloride Tablet
Product Images NDC 50228-136

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 50228-136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (400 mg (500 Tablets Bottle))

This is a description of Levocetirizine Dihydrochloride Tablets. Each film-coated tablet contains 5 mg of the active ingredient, evocetirizine dinyarochlorice, USP. The tablets should be stored at 20-25°C (63-77°F) with excursions permitted up to 15-30% (59-86°F) and dispensed in a tight, light-resistant container with a child-resistant closure. The recommended dosage should be followed as per the package. The tablets are for oral administration and are manufactured by SoeGen Pramaceticas in Heuppauge, NY 11768. Rev: 07/16 is printed on the label.*

FDA Label Image

Package Label-principal Display Panel (100 mg (30 Tablets Bottle))

This is a medication called Exch Fim, which is a coated tablet containing Levocetirizine hydrochloride, at a strength of 5mg. The tablets are meant to be dispensed in light-resistant containers to protect their efficacy. The package insert contains complete dosage recommendations and the medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted from 10°C to 30°C (59°F to 86°F). This medication is meant for oral administration and comes in a pack of 30 tablets, and is only available by prescription. It is manufactured by ScieGen Pharmaceuticals located in Hauppauge, NY.*

FDA Label Image

Levocetirizine 5mg 90ct

This is a description of Levocetirizine Dihydrochloride Tablets, USP which is sold in a package containing 90 coated tablets. The tablets are meant for oral consumption and must be stored in a tightly sealed container away from children, at a controlled room temperature. The complete dosage details are mentioned in the package insert provided. The medicine is manufactured by ScieGen Pharmaceuticals in Hauppauge, NY, and requires a prescription for dispensing.*

FDA Label Image

Chemical Structure (Levocetirizine Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.